CD38 Specific Chimeric Antigen Receptor KHYG-1 Natural Killer Cells: A Potential "Off the Shelf" Therapy for Multiple Myeloma

被引：0
|
作者：
Stikvoort, Arwen [1 ]
Sarkar, Subhashis [2 ]
Poels, Renee [1 ]
van de Donk, Niels W. C. J. [1 ]
Zweegman, Sonja [1 ]
O'Dwyer, Michael E. [2 ]
Mutis, Tuna [1 ]
机构：
[1] Vrije Univ Amsterdam, Med Ctr, Canc Ctr Amsterdam, Dept Hematol, Amsterdam, Netherlands
[2] Natl Univ Ireland Galway, Sch Med, Biomed Sci, Galway, Ireland
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-116403
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3261
引用
收藏
页数：3
相关论文
共 50 条
  • [1] CD38-specific Chimeric Antigen Receptor Expressing Natural Killer KHYG-1 Cells: A Proof of Concept for an "Off the Shelf" Therapy for Multiple Myeloma
    Stikvoort, Arwen
    van der Schans, Jort
    Sarkar, Subhashis
    Poels, Renee
    Ruiter, Ruud
    Naik, Jyoti
    Yuan, Huipin
    de Bruijn, Joost D.
    van de Donk, Niels W. C. J.
    Zweegman, Sonja
    Themeli, Maria
    Groen, Richard
    O'Dwyer, Michael
    Mutis, Tuna
    HEMASPHERE, 2021, 5 (07): : E596
  • [2] Development of Antigen-specific Chimeric Antigen Receptor KHYG-1 Cells for Glioblastoma
    Kang, Chung Hyo
    Kim, Yeongrin
    Lee, So Myoung
    Choi, Sang Un
    Park, Chi Hoon
    ANTICANCER RESEARCH, 2021, 41 (04) : 1811 - 1819
  • [3] Nicotinamide-Expanded Allogeneic Natural Killer Cells with CD38 Deletion, Expressing an Enhanced CD38 Chimeric Antigen Receptor, Target Multiple Myeloma Cells
    Edri, Avishay
    Ben-Haim, Nimrod
    Hailu, Astar
    Brycman, Nurit
    Berhani-Zipori, Orit
    Rifman, Julia
    Cohen, Sherri
    Yackoubov, Dima
    Rosenberg, Michael
    Simantov, Ronit
    Teru, Hideshima
    Kurata, Keiji
    Anderson, Kenneth Carl
    Hendel, Ayal
    Pato, Aviad
    Geffen, Yona
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (24)
  • [4] Daratumumab combined with CD38(-) natural killer cells armed with a CS1 chimeric antigen receptor for the treatment of relapsed multiple myeloma
    Wang, Yufeng
    Zhang, Yibo
    Bnson, Don
    Caligiuri, Michael
    Yu, Jianhua
    CANCER RESEARCH, 2017, 77
  • [5] CD38 Chimeric Antigen Receptor Engineered T Cells As Therapeutic Tools for Multiple Myeloma
    Drent, Esther
    Groen, Richard
    Noort, Willy A.
    van Bueren, Jeroen Lammerts
    Parren, Paul W. H. I.
    Kuball, Jurgen H.
    Sebestyen, Zsolt
    van de Donk, Niels W. C. J.
    Martens, Anton C.
    Lokhorst, Henk M.
    Mutis, Tuna
    BLOOD, 2014, 124 (21)
  • [6] Preclinical Evaluation of Invariant Natural Killer T Cells Modified with CD38 or BCMA Chimeric Antigen Receptors for Multiple Myeloma
    Poels, Renee
    Drent, Esther
    Lameris, Roeland
    Katsarou, Afroditi
    Themeli, Maria
    van der Vliet, Hans J.
    de Gruijl, Tanja D.
    van de Donk, Niels W. C. J.
    Mutis, Tuna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (03) : 1 - 16
  • [7] Characterization of the Therapeutic Effects of Novel Chimeric Antigen Receptor T Cells Targeting CD38 on Multiple Myeloma
    Li, Xiaorui
    Feng, Yaru
    Shang, Fengqin
    Yu, Zhuoying
    Wang, Tieshan
    Zhang, Jing
    Song, Zhiru
    Wang, Ping
    Shi, Bingjie
    Wang, Jianxun
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [8] A Fully Human IgE Specific for CD38 as a Potential Therapy for Multiple Myeloma
    Candelaria, Pierre V.
    Nava, Miguel
    Daniels-Wells, Tracy R.
    Penichet, Manuel L.
    CANCERS, 2023, 15 (18)
  • [9] Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma
    Drent, Esther
    Groen, Richard W. J.
    Noort, Willy A.
    Themeli, Maria
    van Bueren, Jeroen J. Lammerts
    Parren, Paul W. H. I.
    Kuball, Jurgen
    Sebestyen, Zsolt
    Yuan, Huipin
    de Bruijn, Joost
    van de Donk, Niels W. C. J.
    Martens, Anton C. M.
    Lokhorst, Henk M.
    Mutis, Tuna
    HAEMATOLOGICA, 2016, 101 (05) : 616 - 625
  • [10] Specific Targeting of Multiple Myeloma by Dual Split-signaling Chimeric Antigen Receptor T cells Directed against CD38 and CD138
    van der Schans, Jort J.
    Wang, Ziyu
    van Arkel, Jennemiek
    van Schaik, Thijs
    Katsarou, Afroditi
    Ruiter, Ruud
    Baardemans, Thomas
    Yuan, Huipin
    de Bruijn, Joost
    Zweegman, Sonja
    van de Donk, Niels W. C. J.
    Groen, Richard W. J.
    Themeli, Maria
    Mutis, Tuna
    CLINICAL CANCER RESEARCH, 2023, 29 (20) : 4219 - 4229
12345